Objections to publication. An objection has to include a precise request for necessary modifications and shall be considered justified only, if: the proposed publication includes another Party’s Background, Foreground or other Confidential Information; or the proposed publication includes patentable Foreground and the objecting Party anticipates that it wishes to exercise the Option. Upon receipt of an objection, the Parties involved shall discuss a solution in good faith. Within the time limits stated in Article 8.9, the objecting Party may request removal of its Background, Foreground or other Confidential Information, or, if the objection is based on (b) above, a publication delay of at most 60 (sixty) calendar days, in which event the intended publication will be delayed to allow a patent application to be filed. Upon expiration of the term, the publishing Party will be entitled to publish the proposed publication. The Parties acknowledge that if the Project consists of the performance of clinical research that is subject to the Dutch Medical Research Involving Human Subjects Act (WMO), publication arrangements under Sections 8.9 and 8.10 are subject to the Revised CCMO Directive on the Assessment of Clinical Trial Agreements of 30 August 2011, and that in case of any conflict, the latter shall prevail.
Appears in 8 contracts
Samples: Consortium Agreement, Consortium Agreement, Consortium Agreement